SEROQUEL XR 200 mg/1
quetiapine · TABLET, EXTENDED RELEASE · AstraZeneca Pharmaceuticals LP
No Recall History
Plain English
SEROQUEL XR is a tablet, extended release containing quetiapine at 200 mg/1, taken oral. Manufactured by AstraZeneca Pharmaceuticals LP.
Key Facts
- Brand Name
- SEROQUEL XR
- Generic Name
- quetiapine
- NDC Code (Product)
0310-0282- Manufacturer
- AstraZeneca Pharmaceuticals LP
- Strength
- 200 mg/1
- Dosage Form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Marketing Status
- Application #
- NDA022047
- Marketing Start
- 07/16/2007
Recall History
No Recall HistoryFrequently Asked Questions
What is SEROQUEL XR used for?
SEROQUEL XR contains quetiapine. It is a tablet, extended release taken oral. Consult your doctor for specific uses.
Is SEROQUEL XR a controlled substance?
SEROQUEL XR is not classified as a controlled substance by the DEA.
What is the generic name for SEROQUEL XR?
The generic name for SEROQUEL XR is quetiapine. There are 12 other brand versions of quetiapine.
What is the NDC code for SEROQUEL XR 200 mg/1?
The NDC (National Drug Code) for SEROQUEL XR 200 mg/1 is 0310-0282, listed by AstraZeneca Pharmaceuticals LP.
Other Quetiapine Brands
See all →- Quetiapine Fumarate ER400 mg/172189-483
- Quetiapine50 mg/172789-266
- Quetiapine200 mg/176420-518
- QUETIAPINE FUMARATE400 mg/116729-097
- Quetiapine fumarate100 mg/133342-101
- Quetiapine fumarate200 mg/133342-103
- Quetiapine Fumarate200 mg/134908-637
- Quetiapine Fumarate200 mg/150090-7471
- Quetiapine Extended Release300 mg/150228-383
- Quetiapine Fumarate300 mg/150268-634
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)